Average Co-Inventor Count = 8.08
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (17 from 4,948 patents)
2. F. Hoffmann-la Roche Ag (168 patents)
3. Regor Pharmaceuticals, Inc. (0 patent)
17 patents:
1. 12012390 - Flavone compounds for the treatment and prophylaxis of hepatitis B virus disease
2. 11993591 - Chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus disease
3. 11708344 - Flavone derivatives for the treatment and prophylaxis of hepatitis B virus disease
4. RE49481 - Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
5. 11180525 - Process for making 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2, 7-dione compounds useful for the treatment of virus infection
6. 10618929 - 3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2, 7-dione compounds for the treatment and prophylaxis of virus infection
7. 10611748 - Xanthone derivatives for the treatment of hepatitis B virus disease
8. 10189838 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
9. 10040815 - 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
10. 10000512 - Compounds for the treatment of infectious diseases
11. 9441008 - 3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
12. 9206191 - Indazoles for the treatment and prophylaxis of respiratory syncytial virus infection
13. 8871756 - Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
14. 8309581 - Benzimidazole derivatives
15. 8153663 - 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives